Why Switch to Wegovy 1.7mg? Cost Comparison Guide
Wegovy 1.7mg Switch & Save: Making the Transition
Switching to Wegovy 1.7mg represents a strategic decision for patients currently on Mounjaro or those progressing through their dose escalation. This prescription-only medicine offers a compelling alternative, particularly when cost considerations become paramount in long-term weight management. At £139.99 per pen, Wegovy 1.7mg often provides substantial monthly savings compared to equivalent Mounjaro dosing. The 1.7mg dose corresponds approximately to Mounjaro 10mg, though your prescriber will determine the exact transition protocol based on your individual response and tolerance.
EverydayMeds stocks both medications, eliminating the complexity of switching between different pharmacies during your transition. Our clinical team understands the nuances of GLP-1 medication switches, ensuring seamless continuity in your treatment. Returning customers can use code DOSE25 at checkout to maintain optimal pricing, whilst new patients switching from other providers benefit from code FIRST40. The switching process typically involves a brief gap between medications as advised by your prescriber, making our express 24-hour prescriber review service particularly valuable.
Wegovy 1.7mg Pricing Structure and Bundle Savings
Our Wegovy 1.7mg is competitively priced at £139.99 per pen, representing exceptional value in the UK GLP-1 market. For patients planning their transition to maintenance dosing, our Elevate Duo bundle combines 1.7mg with 2.4mg maintenance dose for £369.99, providing a clear pathway through weeks 13-20. This strategic bundling ensures uninterrupted treatment progression without the need for multiple orders. The Consistency 1.7mg bundle offers two pens for £309.99, ideal for patients who may need to remain at this dose for extended periods as advised by their prescriber.
Cost comparison analysis shows potential annual savings of £600-960 when switching from premium-priced alternatives to our Wegovy service. New customers apply code FIRST40 at checkout to achieve these prices, whilst returning patients use DOSE25 to maintain their preferred pricing tier. Our transparent pricing model includes all handling fees, with no hidden costs or subscription requirements. Express prescriber review adds £29.99 for 24-hour turnaround, particularly valuable when coordinating medication switches to minimise treatment gaps.
Clinical Evidence Supporting Wegovy 1.7mg Efficacy
The STEP clinical trial programme demonstrated that patients taking Wegovy 1.7mg as part of their dose escalation achieved significant weight management outcomes. In the pivotal STEP 1 trial, participants reached an average of clinically studied weight loss by 68 weeks when following the complete dose escalation protocol alongside a reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The 1.7mg dose represents a crucial stepping stone in this escalation, where many patients report enhanced appetite control and improved satiety signals.
Comparative studies suggest that the 1.7mg Wegovy dose may offer similar efficacy to Mounjaro 10mg in terms of weight management outcomes, though direct head-to-head trials are limited. The SELECT cardiovascular outcomes trial showed a 20% reduction in major adverse cardiovascular events across the Wegovy dose range, highlighting benefits beyond weight management. These outcomes support the clinical rationale for switching to Wegovy 1.7mg, particularly for patients prioritising cardiovascular risk reduction alongside weight management.
Understanding Wegovy's GLP-1 Mechanism at 1.7mg Dosing
Wegovy 1.7mg works as a GLP-1 receptor agonist, mimicking the natural hormone GLP-1 that regulates appetite and blood sugar levels. At this dosing level, semaglutide significantly enhances satiety signals, helping patients feel satisfied with smaller portions whilst reducing food cravings between meals. The medication slows gastric emptying, prolonging the feeling of fullness after eating, which supports adherence to reduced-calorie dietary plans. Unlike some weight management approaches, Wegovy 1.7mg works through established physiological pathways, targeting the brain's appetite control centres directly. The once-weekly injection schedule at this dose maintains consistent therapeutic levels, providing sustained appetite regulation throughout the seven-day dosing interval. This mechanism becomes particularly pronounced at the 1.7mg level, where many patients report a noticeable shift in their relationship with food and eating behaviours.
Streamlined Ordering Process for Wegovy 1.7mg Switches
Switching to Wegovy 1.7mg through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, specifically designed to capture your medication switching history and current treatment response. Our prescribers review switch requests within 3 working days, or 24 hours with express service, ensuring minimal disruption to your treatment schedule. The assessment covers your current GLP-1 medication, dosing history, tolerance, and reasons for switching, enabling our clinical team to provide tailored switching guidance. Once approved, your Wegovy 1.7mg ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for medication efficacy. Our pharmacy team coordinates with your current provider when necessary, ensuring a smooth transition without compromising your ongoing weight management progress.
Storage and Practical Considerations for Wegovy 1.7mg
Wegovy 1.7mg requires refrigeration at 2-8°C before first use, though it maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration. This extended room temperature stability offers a significant practical advantage over Mounjaro's 21-day limit, making Wegovy ideal for frequent travellers or those with limited refrigeration access. The FlexTouch pen delivery system provides precise 1.7mg dosing with an easy-to-use interface, requiring no mixing or preparation. Patients transitioning from other injection systems often find the FlexTouch mechanism more intuitive, with clear dose counter visibility and smooth injection mechanics. The pen design accommodates various needle preferences, though we recommend using Novo Nordisk needles for optimal performance and patient comfort during the weekly injection routine.
Strategic Dose Escalation Planning with Wegovy 1.7mg
The 1.7mg dose represents weeks 13-16 of the Wegovy escalation protocol, positioning patients just one step away from the 2.4mg maintenance dose. This timing often coincides with peak motivation, as patients typically experience their most noticeable results during this phase. Strategic planning at this dose level involves considering your long-term medication budget, treatment goals, and potential need for extended 1.7mg dosing if tolerance requires slower progression. Some prescribers recommend remaining at 1.7mg for additional weeks if patients achieve satisfactory results without side effects, making cost-effective purchasing essential.
Our Elevate Duo bundle specifically addresses this strategic transition, pairing 1.7mg with 2.4mg maintenance dosing for seamless progression. This approach eliminates the uncertainty of dose timing whilst securing optimal pricing across both dose levels. Patients switching from Mounjaro often find this escalation point ideal for transition, as it aligns with natural treatment evaluation periods whilst maximising potential cost savings throughout their maintenance phase.
Complete Your Wegovy 1.7mg Switch Today
Ready to switch to Wegovy 1.7mg and start saving on your weight management medication? Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and secure your supply at £139.99 per pen. New customers use code FIRST40 at checkout, whilst returning patients apply code DOSE25 to maintain preferred pricing. Our GPhC-registered pharmacy (#9012878) ensures clinical excellence and regulatory compliance throughout your switching process. Express consultation available for urgent switches, with next-day delivery maintaining treatment continuity. Take control of your medication costs whilst maintaining clinical excellence - your weight management journey deserves both affordability and quality care.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
